Corpus Intelligence IC Memo — SHANNON MEDICAL CENTER 2026-04-26 03:59 UTC
IC Memo — SHANNON MEDICAL CENTER
Investment Committee Memorandum | TX | 404 beds | Grade B | EBITDA uplift $44.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SHANNON MEDICAL CENTER

CCN 450571 | TOM GREEN, TX | 404 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SHANNON MEDICAL CENTER is a 404-bed suburban community hospital in TOM GREEN, TX with $610.6M in net patient revenue and a 12.6% operating margin. The hospital serves a payer mix of 30.0% Medicare, 13.1% Medicaid, and 56.9% commercial.

Thesis: Platform Growth. Our ML models identify $44.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.6% to 20.0% (+736bps).

Net Revenue HCRIS$610.6M
Current EBITDA COMPUTED$77.2M
Operating Margin COMPUTED12.6%
Occupancy HCRIS56.2%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS25.8%
Distress Probability ML49.1%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
98
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 12.6% places it above the state median. Among 98 size-comparable peers (202-808 beds), the median margin is 3.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (202-808), prioritizing same-state peers. 98 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SHANNON MEDICAL CENTER (Target)TX404$610.6M12.6%
UT MD ANDERSON CANCER CENTERTX721$4.90B-0.8%
UT SOUTHWESTERN UNIVERSITY HOSTX737$2.28B-4.6%
SCOTT AND WHITE MEMORIAL HOSPITX616$1.85B-10.5%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
COOK CHILDRENS MEDICAL CENTERTX423$1.51B16.5%
BAYLOR UNIVERSITY MEDICAL CTRTX800$1.26B0.4%
CHI ST LUKES HEALTH BAYLOR MEDTX628$1.10B-9.5%
UNIVERSITY HEALTH SYSTEMTX657$1.10B-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $44.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$12.8M+210bp18mo
Cost to Collect4.5%2.5%$12.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$12.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$7.4M+122bp9mo
Clean Claim Rate88.0%96.0%$391K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$12.8M
Cost to Collect
$12.2M
Denial Rate Reduction
$12.1M
A/R Days Reduction
$7.4M
Clean Claim Rate
$391K
Total EBITDA Uplift$44.9M
Current EBITDA$77.2M
+ RCM Uplift+$44.9M
Pro Forma EBITDA$122.2M
Current Margin12.6%
Pro Forma Margin20.0%
WC Released (1x)$23.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$118.8M$958.9M8.07x51.8%
Base (11x exit)10.0x11.0x$118.8M$1.09B9.20x55.9%
Bull Case9.0x11.0x$106.9M$1.28B11.97x64.3%
Bull (12x exit)9.0x12.0x$106.9M$1.43B13.36x67.9%
Bear Case11.0x10.0x$130.7M$695.5M5.32x39.7%
Bear (11x exit)11.0x11.0x$130.7M$807.5M6.18x43.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 98 hospitals with 202-808 beds
  • Same-state prioritization (n=99)
  • Comp margins: P25=-9.4% / P50=3.7% / P75=14.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.